Abstract:Monoterpene indole alkaloids (MIAs) are a class of natural products comprised of thousands of structurally unique bioactive compounds with significant therapeutic values. Due to difficulties associated with isolation from native plant species and organic synthesis of these structurally complex molecules, microbial production of MIAs using engineered hosts are highly desired. In this work, we report the engineering of fully integrated Saccharomyces cerevisiae strains that allow de novo access to strictosidine, the universal precursor to thousands of MIAs at 30-40 mg/L. The optimization efforts were based on a previously reported yeast strain that is engineered to produce high titers of the monoterpene precursor geraniol through compartmentalization of mevalonate pathway in the mitochondria. Our approaches here included the use of CRISPR-dCas9 interference to identify mitochondria diphosphate transporters that negatively impact the titer of the monoterpene, followed by genetic inactivation; the overexpression of transcriptional regulators that increase cellular respiration and mitochondria biogenesis. Strain construction included the strategic integration of genes encoding both MIA biosynthetic and accessory enzymes into the genome under a variety of constitutive and inducible promoters. Following successful de novo production of strictosidine, complex alkaloids belonging to heteroyohimbine and corynantheine families were reconstituted in the host with introduction of additional downstream enzymes. We demonstrate that the serpentine/alstonine pair can be produced at ∼5 mg/L titer, while corynantheidine, the precursor to mitragynine can be produced at ∼1 mg/L titer. Feeding of halogenated tryptamine led to the biosynthesis of analogs of alkaloids in both families. Collectively, our yeast strain represents an excellent starting point to further engineer biosynthetic bottlenecks in this pathway and to access additional MIAs and analogs through microbial fermentation. One sentence summary: An Saccharomyces cerevisiae-based microbial platform was developed for the biosynthesis of monoterpene indole alkaloids, including the universal precursor strictosidine and further modified heteroyohimbine and corynantheidine alkaloids.

Metabolic engineering of Saccharomyces cerevisiae for chelerythrine biosynthesis

Enhancement of Abscisic Acid Biosynthesis in Saccharomyces Cerevisiae Via Multidimensional Engineering

Switching Carbon Metabolic Flux for Enhancing the Production of Sesquiterpene-Based High-Density Biofuel Precursor in Saccharomyces Cerevisiae

Advances in Metabolic Engineering of Saccharomyces Cerevisiae for Terpenoids Biosynthesis

Combinatorial Metabolic Engineering of Saccharomyces Cerevisiae for Improved Production of 7-Dehydrocholesterol

Systems Metabolic Engineering of Saccharomyces cerevisiae for the High-Level Production of (2S)-Eriodictyol

Metabolic Engineering Strategies for De Novo Biosynthesis of Sterols and Steroids in Yeast.

De Novo Synthesis of Chrysin in Saccharomyces cerevisiae

Systematic Engineering of Saccharomyces cerevisiae Chassis for Efficient Flavonoid-7- O -Disaccharide Biosynthesis

Alleviation of metabolic bottleneck by combinatorial engineering enhanced astaxanthin synthesis in Saccharomyces cerevisiae.

Engineering of Saccharomyces cerevisiae for 24-Methylene-Cholesterol Production

Improved Linalool Production in Saccharomyces Cerevisiae by Combining Directed Evolution of Linalool Synthase and Overexpression of the Complete Mevalonate Pathway

Metabolic engineering of Saccharomyces cerevisiae for the biosynthesis of ethyl crotonate

Multi‐modular engineering of Saccharomyces cerevisiae for high‐titre production of tyrosol and salidroside

Multilevel engineering of the upstream module of aromatic amino acid biosynthesis in Saccharomyces cerevisiae for high production of polymer and drug precursors

Metabolic engineering of Saccharomyces cerevisiae for the synthesis of valuable chemicals

Metabolic Engineering of Saccharomyces cerevisiae for High-Level Production of Chlorogenic Acid from Glucose

Metabolic engineering of Saccharomyces cerevisiae for enhanced production of caffeic acid

Rewiring central carbon metabolism for tyrosol and salidroside production in Saccharomyces cerevisiae

Metabolic engineering of Escherichia coli for N-methylserotonin biosynthesis

Engineered biosynthesis of plant heteroyohimbine and corynantheine alkaloids in Saccharomyces cerevisiae